Get the Stockscreener App
1.02
7.08%
0.0675
Neuroone Medical Technologies Corp stock is traded at $1.02, with a volume of 130.57K.
It is up +7.08% in the last 24 hours and down -10.53% over the past month.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
See More
Previous Close:
$0.9526
Open:
$0.96
24h Volume:
130.57K
Relative Volume:
0.53
Market Cap:
$31.48M
Revenue:
$2.82M
Net Income/Loss:
$-13.47M
P/E Ratio:
-1.50
EPS:
-0.68
Net Cash Flow:
$-13.61M
1W Performance:
+0.00%
1M Performance:
-10.53%
6M Performance:
+22.89%
1Y Performance:
-8.93%
1-Day Range:
$0.935
$1.02
1-Week Range:
$0.86
$1.0691
52-Week Range:
$0.551
$1.50
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Name
Neuroone Medical Technologies Corp
Sector
Industry
Phone
(952) 426-1383
Address
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1898 | 400.55M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.73 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.68 | 115.41M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
5.15 | 66.99M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.17 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-29-22 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Stock (NMTC) Latest News
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
NeuroOne speeds up FDA submission for nerve ablation system - Investing.com
NeuroOne Speeds Up FDA Timeline: Revolutionary Facial Pain Treatment Could Hit Market Earlier Than Expected - StockTitan
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Barchart
Can NeuroOne's Upcoming Investor Presentation Signal New Growth in Neurological Tech? - StockTitan
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Call Transcript - MSN
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge - MSN
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus.com
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge By Investing.com - Investing.com Canada
NeuroOne Medical Technologies Corp Reports Q1 FY2025 Earnings: E - GuruFocus.com
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results - TradingView
Q1 Earnings Breakthrough: NeuroOne Hits Record $6.3M Revenue as Product Sales Triple - StockTitan
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. - EIN News
NeuroOne Medical Earnings Alert: Key Q1 2025 Results and Strategic Updates Coming February 12 - StockTitan
NeuroOne regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
NeuroOne regains Nasdaq compliance with share price - Investing.com
Breakthrough Brain Tech Company Posts Massive Revenue Jump After Crucial Nasdaq Win - StockTitan
Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Inari Medical (NASDAQ:NARI) - Defense World
NeuroOne CEO shares company strategy in letter to shareholders - Investing.com
NeuroOne faces Nasdaq delisting over share price issue By Investing.com - Investing.com Australia
NeuroOne Medical Technologies Faces Delisting from Nasdaq Due to Non-Compliance - Defense World
NeuroOne faces Nasdaq delisting over share price issue - Investing.com India
NeuroOne Reports Record Revenue Boost in Q1 2025 - Yahoo Finance
NeuroOne Medical Revenue Surges 520% to Record $6.2M, Boosted by Zimmer Biomet Deal - StockTitan
NeuroOne Medical Projects 190% Revenue Growth, Expands Zimmer Biomet Partnership - StockTitan
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11: 00 a.m. EST - Marketscreener.com
NeuroOne Medical Projects 190% Revenue Growth, Sets Investor Webinar to Showcase Expansion - StockTitan
NeuroOne Medical Technologies Reports Increased Product Revenue and Strategic Partnerships in 2024 - Defense World
NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ... - Yahoo Finance
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation - Investing.com Australia
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation By Investing.com - Investing.com South Africa
NeuroOne Medical Technologies Corp Reports Q4 Net Loss of $3.3 M - GuruFocus.com
NeuroOne Medical Projects 190% Revenue Growth for 2025 After Record-Breaking Year - StockTitan
Neuroone stock hits 52-week low at $0.56 amid market challenges - Investing.com
NeuroOne Medical Technologies Sets Q4 2024 Earnings Release Date - StockTitan
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing - The Globe and Mail
Nashville InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
Neuroone stock hits 52-week low at $0.59 amid market challenges - Investing.com
AWM Investment Company, Inc. Increases Stake in NeuroOne Medical Technologies Corp - GuruFocus.com
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event - Yahoo Finance
NeuroOne ends loan agreement with Growth Opportunity Funding - Investing.com
Zimmer Biomet to Present at Jefferies London Healthcare Conference - Marketscreener.com
NeuroOne agree $3m partnership with Zimmer Biomet - Yahoo! Voices
NeuroOne expands agreement with Zimmer Biomet for commercialisation of OneRF ablation system - NeuroNews International
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
NeuroOne Expands OneRF Distribution Deal with Zimmer Biomet - MPO-mag
NeuroOne expands distribution with Zimmer Biomet - Investing.com
NeuroOne Medical Technologies adjusts executive severance terms - Investing.com
Neuroone Medical Technologies Corp Stock (NMTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):